Cargando…

Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness

Pituitary null cell adenoma is a challenging clinical condition, and its pathogenesis remains to be elucidated. We performed this study to determine the roles of C5orf66-AS1, NORAD, and TINCR in the pathogenesis and invasion of pituitary null cell adenomas. Expression of the three long non-coding RN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Guoqiang, Li, Chuzhong, Xie, Weiyan, Wang, Zhuang, Gao, Hua, Cao, Lihua, Hao, Lingtong, Zhang, Yazhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562005/ https://www.ncbi.nlm.nih.gov/pubmed/28656268 http://dx.doi.org/10.3892/or.2017.5739

Ejemplares similares

Identifying critical protein-coding genes and long non-coding RNAs in non-functioning pituitary adenoma recurrence
por: Guo, Jing, et al.
Publicado: (2021)

Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
por: Guo, Jing, et al.
Publicado: (2021)

Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas
por: Xie, Weiyan, et al.
Publicado: (2016)

Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles
por: Cheng, Sen, et al.
Publicado: (2019)

The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2019)

Germline mutations in MEN1 are associated with the tumorigenesis of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2020)

A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas
por: Cheng, Sen, et al.
Publicado: (2021)

Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas
por: Liu, Chunhui, et al.
Publicado: (2016)

Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma
por: Cheng, Sen, et al.
Publicado: (2020)

Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment
por: Wu, Jiangping, et al.
Publicado: (2023)

CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial–mesenchymal transition
por: Li, Bin, et al.
Publicado: (2019)

CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression
por: Xie, Weiyan, et al.
Publicado: (2014)

JAG1, Regulated by microRNA-424-3p, Involved in Tumorigenesis and Epithelial–Mesenchymal Transition of High Proliferative Potential-Pituitary Adenomas
por: Chen, Yiyuan, et al.
Publicado: (2020)

Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
por: Nie, Ding, et al.
Publicado: (2021)

Analysis of the Prognostic and Immunological Role of HSPB1 in Pituitary Adenoma: A Potential Target for Therapy
por: Zhao, Sida, et al.
Publicado: (2023)

Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype
por: Chen, Yiyuan, et al.
Publicado: (2020)

Alterations of regional homogeneity and functional connectivity in pituitary adenoma patients with visual impairment
por: Song, Guidong, et al.
Publicado: (2017)

Null-Cell Ectopic Pituitary Adenoma of the Nasal Cavity
por: Figaro, Nicholas, et al.
Publicado: (2023)

The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas
por: Zhenye, Li, et al.
Publicado: (2014)

Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data
por: Zhao, Peng, et al.
Publicado: (2015)

Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma
por: Wang, Shousen, et al.
Publicado: (2019)

Corrigendum to “Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data”
por: Zhao, Peng, et al.
Publicado: (2018)

Whole-exome sequencing identifies variants in invasive pituitary adenomas
por: Lan, Xiaolei, et al.
Publicado: (2016)

Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas
por: Yao, Xiaohui, et al.
Publicado: (2017)

Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model
por: Cheng, Sen, et al.
Publicado: (2019)

Comparative Efficacy of AZD9496 and Fulvestrant on the Growth of Pituitary Adenoma via Blocking JAK2/STAT5B Pathway
por: Liu, Qian, et al.
Publicado: (2023)

A two-circRNA signature predicts tumour recurrence in clinical non-functioning pituitary adenoma
por: Guo, Jing, et al.
Publicado: (2019)

Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets
por: Feng, Jie, et al.
Publicado: (2019)

Integration of Proteomics and Metabolomics Revealed Metabolite–Protein Networks in ACTH-Secreting Pituitary Adenoma
por: Feng, Jie, et al.
Publicado: (2018)

In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma
por: Yuan, Taoyang, et al.
Publicado: (2021)

Risk factors and management associated with postoperative cerebrospinal fluid leak after endoscopic endonasal surgery for pituitary adenoma
por: Li, Bin, et al.
Publicado: (2022)

LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis
por: Zhao, Peng, et al.
Publicado: (2021)

Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas
por: Yao, Xiaohui, et al.
Publicado: (2019)

Differential non-coding RNAs expression profiles of invasive and non-invasive pituitary adenomas
por: Beylerli, Ozal, et al.
Publicado: (2021)

SUN-135 Characterization of Transcription Factor Immunostaining and Null Cell Adenoma Status in Hormone Negative Pituitary Adenomas
por: Baertsch, Hans C, et al.
Publicado: (2020)

Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors
por: Chen, Yiyuan, et al.
Publicado: (2020)

PMON126 Null Cell Adenoma With Low Ki-67 Presenting as Recurrent Pituitary Mass
por: Tiu, Leo, et al.
Publicado: (2022)

Analysis of whole genome-wide microRNA transcriptome profiling in invasive pituitary adenomas and non-invasive pituitary adenomas
por: Zhang, Chao, et al.
Publicado: (2019)

Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence
por: Landeiro, José Alberto, et al.
Publicado: (2015)

Role of matrix Metalloproteinases in pituitary adenoma invasion
por: Yang, Chengxian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qnvtoaiqgpi42ko5ktqe8v3n8j